课题基金 / 基金详情

Reduced EtO emissions to safeguard biomedical supply chains

Reduced EtO emissions to safeguard biomedical supply chains
减少环氧乙烷排放以保护生物医学供应链
批准号:
10547016
负责人:
Melissa A Petruska
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-20 至 2023-08-31

项目摘要

项目成果

Melissa A Petruska的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary/Abstract The overarching goal of this project is to protect the nation’s supply chain of critical medical devices that are sterilized using ethylene oxide (EtO). Despite the search for alternative approaches, numerous types of single-use devices are sterilized with EtO. These devices, including catheters, heart valves, and tracheostomy tubes, are critical to routine and life-saving procedures and therapies. As regulation of EtO emissions and community and worker exposure levels continues to become more stringent, there is a threat that supply chains for critical devices will be disrupted, in turn threatening the health and well-being of the nation. The specific objectives of this project include the development of a novel photocatalytic method to mitigate EtO at levels that are hazardous but difficult to address with existing adsorptive and thermal catalytic approaches. Specifically, the technology addresses concentrations in the range of 10 ppm and below. The technology can be used to mitigate EtO from existing sterilization plants as an adjunct to stack scrubbers, as well as deployed to address ambient levels of EtO in plants and warehouses. Objectives include determining operating conditions at which low concentrations of EtO (<10 ppm) are oxidized at 99% destruction and removal efficiency (DRE), identifying optimum photocatalyst and parameter space for achieving high DRE, developing a prototype photoreactor operating at 20 cfm capable of 99% EtO DRE that is scalable to commercial requirements, and evaluating the performance of the prototype for a target 99% EtO DRE at 20 cfm. The specific aims are determining operating parameters at lab-scale, building a scalable prototype reactor capable of 20 cfm operation, and evaluating the performance of the prototype at 20 cfm for a target of 99% EtO DRE. Study designs are centered around systematic catalyst modifications and exploration of gas flow / illumination geometries. Standard and cutting-edge detection approaches that are capable of measuring EtO into the low ppb and ppt ranges will be used in the experimental program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reduced EtO emissions to safeguard biomedical supply chains
  • 批准号:
    10827793
  • 项目类别:
  • 资助金额:
    $59.1万
  • 财政年份:
    2022
  • 负责人:
    Melissa A Petruska
  • 依托单位:
国内基金
海外基金
组蛋白甲基化酶SETD2和RNA甲基化酶METTL3串扰调控选择性剪接体AML1-ETO9a的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    李永辉
  • 依托单位:
BAHD1在AML1-ETO阳性儿童急性髓系白血病中的表达、促进白血病发生和复发分子机制研究
  • 批准号:
    82370156
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    范会涛
  • 依托单位:
AML1-ETO/SETD8新型复合体增强染色质可及性维持t(8;21)AML白血病干细胞干性的新机制
  • 批准号:
    82304555
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20万元
  • 批准年份:
    2023
  • 负责人:
    苏永伟
  • 依托单位:
双靶向AML1-ETO融合癌蛋白与c-Kit突变体治疗t(8;21)急性髓系白血病的分子机制研究
  • 批准号:
    82370151
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    俞文娟
  • 依托单位: